Tajikistan Simplified State Registration Procedure 2026: Emergency Channel Outlook and Action Plan

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Tajikistan maintains a simplified state registration channel, applicable to specific situations such as military operations, emergencies and epidemic outbreaks. Article 1, item 15 of Law No. 1893 defines simplified state registration as: registration under which the requirements for submitted documents for medicines and medical goods are relaxed and review periods are shortened in situations provided for by this Law, such as the occurrence of military operations, emergencies, epidemic outbreaks and other situations. Article 17(9) further provides that, for medicines and medical goods intended for the prevention and treatment of conditions arising under military operations, emergencies and epidemic outbreaks, as well as the prevention and treatment of diseases caused by adverse chemical, biological and radiation factors, the simplified state registration procedure is determined by the authorized state body in the healthcare sphere jointly with the State Supervisory Body for Pharmaceutical Activity.

2. Legal basis

ItemContent
Legal basisLaw of the Republic of Tajikistan No. 1893 of July 19, 2022, On Medicines, Medical Goods and Pharmaceutical Activity (repromulgated by Law No. 2181 of May 14, 2025)
Definition provisionArticle 1, item 15: simplified state registration — registration under which the requirements for submitted documents for medicines and medical goods are relaxed and review periods are shortened in situations provided for by this Law, such as the occurrence of military operations, emergencies, epidemic outbreaks and other situations
Procedure provisionArticle 17(9): the simplified state registration procedure for medicines and medical goods intended for use under military operations, emergencies and epidemic outbreaks, and for the prevention and treatment of diseases caused by adverse chemical, biological and radiation factors, is determined by the authorized state body in the healthcare sphere jointly with the State Supervisory Body for Pharmaceutical Activity; the procedure is developed and approved by the authorized state body in the healthcare sphere
Accompanying importArticle 26(7): the authorized state body in the healthcare sphere has the right, in the event of natural disasters and emergencies (including infectious disease epidemics), subject to strict supervision of their use, to permit the one-time import of medicines and medical goods not registered in Tajikistan
Accompanying importArticle 26(8), item 9: import and export of limited quantities for the purpose of preventing and eliminating emergencies
Ordinary registrationArticle 17(1): production, sale and use are premised on completed state registration
Fee waiverArticle 17(11): medicines for the diagnosis and treatment of rare diseases, as well as medicines and medical goods imported into Tajikistan as humanitarian aid for the implementation of state health programs, are exempt from registration fees

3. Expert insights

Insight 1: The applicable situations of the simplified channel are an exhaustive enumeration with a catch-all, but even the catch-all is confined to situations provided for by this Law. The wording of Article 1, item 15 is military operations, the occurrence of emergencies, epidemic outbreaks and other situations provided for by this Law — the qualifier before other situations is provided for by this Law, which means the catch-all cannot be expanded without limit, and enterprises cannot invoke commercial urgency to claim access to the simplified channel.

Insight 2: Article 17(9) is a joint-two-authority structure, in contrast with the single-authority rule-making of the ordinary channel. The ordinary registration procedures for medical goods are developed and approved by the Ministry of Health alone (Article 17(12)), whereas the simplified procedure requires the Ministry of Health to act jointly with the State Supervisory Body for Pharmaceutical Activity. The implication of this procedural design is that activation of the simplified channel involves judgments at the execution level and requires confirmation by both authorities. The note from GRZAN is: when considering the simplified channel, the counterpart for communication is not one authority but two.

Insight 3: The simplified channel and the one-time import of unregistered goods under Article 26(7) are two independent mechanisms that must be used in tandem. Article 17(9) addresses acceleration at the registration stage; Article 26(7) addresses the exception at the import stage. In natural disaster or epidemic scenarios, enterprises usually need to invoke both: first obtain the one-time import permit under Article 26(7), then process the simplified registration under Article 17(9). Handling only one produces a split — the goods can enter but cannot be used, or the procedure is compliant but the goods cannot enter.

Insight 4: The fee waiver of Article 17(11) and the simplified channel are two different benefit lines. Paragraph 11 waives registration fees for medicines for the diagnosis and treatment of rare diseases and for medicines and medical goods imported as humanitarian aid to implement state health programs. Its applicable objects do not overlap with the applicable situations of the simplified channel: rare disease and aid products are not necessarily in an emergency state, and products in an emergency state are not necessarily rare disease or aid products. When calculating costs, enterprises should assess and apply for the two benefit lines separately.

4. Practical recommendations

  1. Position the simplified channel as an emergency mechanism, not an ordinary pathway. GRZAN does not recommend that clients include the simplified channel in ordinary business plans. Its premise is a statutory emergency situation, and confirmation requires the two authorities acting jointly; the enterprise has no unilateral right to invoke it.
  2. Establish a trigger determination process for emergency situations. It is recommended that the internal compliance system specify what level of humanitarian request, government procurement or international organization purchase may trigger an assessment of the simplified channel. The determination basis should return to the situations enumerated in Article 1, item 15.
  3. Prepare both the registration and the import applications in parallel. Where the simplified channel applies, prepare simultaneously the simplified registration application under Article 17(9) and the one-time import permit application under Article 26(7), avoiding a split between stages.
  4. Assess the fee waiver of Article 17(11) separately. For rare disease related products and humanitarian aid supplies, submit the fee waiver application together with the dossier, and prepare documentation demonstrating the correspondence between the aid documents and the state health program.

5. Verification checklist

  • □ Confirmed the situation for using the simplified channel falls within the enumeration of Article 1, item 15
  • □ Confirmed the simplified procedure is determined by the Ministry of Health jointly with the supervisory body (Article 17(9)), with both authorities as counterparts
  • □ Prepared in parallel the one-time import permit application under Article 26(7)
  • □ Assessed separately eligibility for the registration fee waiver of Article 17(11)
  • □ Prepared documentation of the correspondence between humanitarian aid documents and the state health program (if applicable)
  • □ Confirmed the simplified channel is not included in the market access model of ordinary business plans
  • □ Established a trigger determination process and responsible positions for emergency situations

Regulatory information verified as of October 29, 2026.

In the Central Asian market, the core capabilities of GRZAN concentrate on three points: first, distinguishing the different legal status of each market within the Eurasian Economic Union — Kazakhstan and Kyrgyzstan are full member states offering a dual choice between the national track and the union track; Uzbekistan is an observer state with only the national track; Tajikistan and Turkmenistan are outside the union framework and must follow purely national procedures. Second, local authorized representative services, acting as the statutory representative of manufacturers in these countries and undertaking registration submission, regulatory communication and post-market reporting obligations. Third, quality system and testing support, assisting in establishing a quality management system that meets ISO 13485 requirements and connecting with locally accredited laboratory resources.

Business inquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail